Exogenous IL2 partially reverts CML non-reactivity acquired during prophylactic immunosuppression with cyclosporin A of human allograft recipients

Immunobiology. 1986 Aug;172(1-2):21-32. doi: 10.1016/S0171-2985(86)80050-X.

Abstract

Proliferative and cytolytic lymphocyte responses and the influence of exogenous interleukin 2 (IL2) on cell-mediated lympholysis (CML) reactivity were evaluated in 12 allograft recipients. Responses were induced by mitogenic lectins or by donor and third-party cells. Patients were tested immediately before transplantation (Tx) and one and three months after grafting. Prophylactic immunosuppression consisted of Cyclosporin A (CyA) and low-dose prednisone (P). Analysis of post transplant cells revealed a reduced overall proliferative T cell responsiveness induced by both alloantigens and mitogenic lectins. No evidence for donor-specific reduction of MLC responses was seen. Overall CML reactivity of post-Tx lymphocytes was also impaired. This was accompanied by donor-specific CML non-reactivity in six of seven patients with quiescent grafts. In these patients, the cytolytic potential against donor cells could be restored when maximal T cell help via exogenous IL2 was provided.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Cyclosporins / immunology
  • Female
  • Humans
  • Immunosuppressive Agents
  • Interleukin-2 / administration & dosage
  • Interleukin-2 / pharmacology*
  • Male
  • Middle Aged
  • Prednisone / immunology
  • T-Lymphocytes, Cytotoxic / analysis
  • T-Lymphocytes, Cytotoxic / drug effects*

Substances

  • Cyclosporins
  • Immunosuppressive Agents
  • Interleukin-2
  • Prednisone